Thoratec Pushes Back Approval Timeline For HeartMate II After FDA Meeting
This article was originally published in The Gray Sheet
Executive Summary
Thoratec has pushed back the expected approval timeframe for its HeartMate II continuous flow left ventricular assist device following a "100-day" meeting with FDA on May 1